BioVenture VoiCes with Chris Garabedian
by BiotechTV
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 15 chart positions in 15 markets.
By chart position
- 🇬🇧GB · Life Sciences#27100K to 300K
- 🇺🇸US · Life Sciences#7230K to 100K
- 🇦🇺AU · Life Sciences#1065K to 30K
- 🇰🇷KR · Life Sciences#7100K to 300K
- 🇯🇵JP · Life Sciences#1191K to 10K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
142K to 450K🎙 Weekly cadence·36 episodes·Last published 1mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
283K to 900K🇬🇧33%🇰🇷33%🇺🇸11%+12 more - Active Followers
Loyal subscribers who consistently listen
85K to 270K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 12 epsHost
Recent guests
Recent episodes
Episode 43: Lightstone Venture's Mike Carusi
Jul 13, 2026
1h 07m 11s
Episode 42: Nextech's Thilo Schroeder
Jun 15, 2026
1h 05m 09s
Episode 41: Forbion's Nanna Lüneborg
Jun 1, 2026
1h 02m 00s
Episode 40: GV's Krishna Yeshwant
May 18, 2026
1h 19m 12s
Episode 39: SV Health Investors' Kate Bingham
May 4, 2026
1h 12m 46s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 7/13/26 | medical devicesinvesting+3 | Mike Carusi | Lightstone VentureBiotechTV | — | Mike CarusiLightstone Venture+4 | — | 1h 07m 11s | ||
| 6/15/26 | investment philosophyprecision oncology+3 | Thilo Schroeder | Revolution MedicinesPeloton+2 | — | investmentprecision oncology+5 | — | 1h 05m 09s | ||
| 6/1/26 | investment approachlife sciences+4 | Nanna Lüneborg | AIForbion | China | ForbionNanna Lüneborg+5 | — | 1h 02m 00s | ||
| 5/18/26 | investingtechnology+4 | Krishna Yeshwant | GVAlphabet | Silicon ValleyBoston | GVKrishna Yeshwant+5 | — | 1h 19m 12s | ||
| 5/4/26 | investment approacheshealthcare+4 | Kate Bingham | SV HealthVertex+2 | — | Kate BinghamSV Health+5 | — | 1h 12m 46s | ||
| 4/20/26 | venture capitalbiotechnology+3 | Jason Fuller | Langer LabMIT+4 | — | venturebiotech+3 | — | 1h 05m 48s | ||
| 3/23/26 | investmentbiotech+3 | Simeon George | SR OneGSK | — | SR OneGSK+3 | — | 1h 06m 16s | ||
| 3/9/26 | venture capitaltherapeutics+3 | Jim Healy | Sofinnova Investments | — | venture capitalSofinnova Investments+5 | — | 1h 01m 37s | ||
| 2/23/26 | venture capitalbiotech investing+3 | Jessica Owens | Kleiner PerkinsVersant Ventures+3 | — | venture capitalbiotech+7 | — | 1h 09m 09s | ||
| 2/9/26 | biotechhealthcare+3 | Brett Zbar | Aisling CapitalForesight Capital+1 | — | Brett ZbarGeneral Atlantic+5 | — | 1h 07m 01s | ||
| 1/26/26 | investmentbiotech+3 | Art Pappas | Pappas Capital | — | Pappas CapitalArt Pappas+3 | — | 58m 12s | ||
| 1/11/26 | leadershiprisk taking+3 | Bob Nelsen | ARCH Venture PartnersUnited States+1 | WashingtonUniversity of Chicago | leadershiprisk taking+3 | — | 1h 15m 05s |
Showing 12 of 12
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Similar Audience Demographics
Podcasts that attract a similar listener profile
Chart history for BioVenture VoiCes with Chris Garabedian
Peaked at #7 in South Korea, top 10 in 1 of 16 tracked markets, currently #7 in South Korea.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| South Korea | — | #7 | #7 | — |
| GR | — | #24 | #24 | — |
| United Kingdom | — | #27 | #27 | — |
| HK | — | #27 | #27 | — |
| SG | — | #37 | #37 | — |
| South Korea | — | #46 | #46 | — |
| CH | — | #60 | #60 | — |
| Norway | — | #69 | #69 | — |
| United States | — | #72 | #72 | — |
| TW | — | #79 | #79 | — |
| IL | — | #82 | #82 | — |
| Ireland | — | #89 | #89 | — |
| Australia | — | #106 | #106 | — |
| Japan | — | #119 | #119 | — |
| India | — | #137 | #137 | — |
| France | — | #162 | #162 | — |
Chart Positions
16 placements across 15 markets.
Chart Positions
16 placements across 15 markets.